Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response.
DiNapoli
Joshua M
JM
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-MSC, USA.
Yang
Lijuan
L
Samal
Siba K
SK
Murphy
Brian R
BR
Collins
Peter L
PL
Bukreyev
Alexander
A
D000281:Administration, Intranasal; D000818:Animals; D057134:Antibodies, Neutralizing / Q000032:analysis*; D000914:Antibodies, Viral / Q000032:analysis*; D001769:Blood / Q000276:immunology; D012634:Bodily Secretions / Q000276:immunology; D046129:Ebola Vaccines / Q000008:administration & dosage / Q000276:immunology*; D029043:Ebolavirus / Q000235:genetics / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005822:Genetic Vectors; D019142:Hemorrhagic Fever, Ebola / Q000276:immunology / Q000517:prevention & control; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D008253:Macaca mulatta; D009500:Neutralization Tests; D009522:Newcastle disease virus / Q000235:genetics*; D012137:Respiratory System / Q000276:immunology*; D014611:Vaccination / Q000379:methods*
D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D046129:Ebola Vaccines; D007070:Immunoglobulin A; D007074:Immunoglobulin G